Recombinant multi-species TADA2L/TADA2A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TADA2L/TADA2A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Many DNA-binding transcriptional activator proteins enhance the initiation rate of RNA polymerase II-mediated gene transcription by interacting functionally with the general transcription machinery bound at the basal promoter. Adaptor proteins are usually required for this activation, possibly to acetylate and destabilize nucleosomes, thereby relieving chromatin constraints at the promoter. The protein encoded by this gene is a transcriptional activator adaptor and has been found to be part of the PCAF histone acetylase complex. Several alternatively spliced transcript variants encoding different isoforms of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2009]
The Alternative Names of target: ADA2,ADA2A,D030022J10Rik,KL04P,TADA2A,TADA2L,Tada2a,Tada2l,Transcriptional adapter 2-alpha,Transcriptional adapter 2-like (ADA2-like protein),hADA2

Target products collectionGo to TADA2L/TADA2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11604-Ag-1/ GM-Tg-hg-IP11604-Ag-2 Human TADA2L/TADA2A protein Human
GM-Tg-rg-IP11604-Ag-1/ GM-Tg-rg-IP11604-Ag-2 Rat TADA2L/TADA2A protein Rat
GM-Tg-mg-IP11604-Ag-1/ GM-Tg-mg-IP11604-Ag-2 Mouse TADA2L/TADA2A protein Mouse
GM-Tg-cynog-IP11604-Ag-1/ GM-Tg-cynog-IP11604-Ag-2 Cynomolgus/Rhesus macaque TADA2L/TADA2A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11604-Ag-1/ GM-Tg-felg-IP11604-Ag-2 Feline TADA2L/TADA2A protein Feline
GM-Tg-cang-IP11604-Ag-1/ GM-Tg-cang-IP11604-Ag-2 Canine TADA2L/TADA2A protein Canine
GM-Tg-bovg-IP11604-Ag-1/ GM-Tg-bovg-IP11604-Ag-2 Bovine TADA2L/TADA2A protein Bovine
GM-Tg-equg-IP11604-Ag-1/ GM-Tg-equg-IP11604-Ag-2 Equine TADA2L/TADA2A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11604-Ag-1/ GM-Tg-hg-IP11604-Ag-2; GM-Tg-rg-IP11604-Ag-1/ GM-Tg-rg-IP11604-Ag-2;
GM-Tg-mg-IP11604-Ag-1/ GM-Tg-mg-IP11604-Ag-2; GM-Tg-cynog-IP11604-Ag-1/ GM-Tg-cynog-IP11604-Ag-2;
GM-Tg-felg-IP11604-Ag-1/ GM-Tg-felg-IP11604-Ag-2; GM-Tg-cang-IP11604-Ag-1/ GM-Tg-cang-IP11604-Ag-2;
GM-Tg-bovg-IP11604-Ag-1/ GM-Tg-bovg-IP11604-Ag-2; GM-Tg-equg-IP11604-Ag-1/ GM-Tg-equg-IP11604-Ag-2
Products Name TADA2L/TADA2A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TADA2L/TADA2A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TADA2L/TADA2A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.